Loading...
XNAS
XXII
Market cap5mUSD
Jun 12, Last price  
0.66USD
1D
-5.11%
1Q
-61.66%
Jan 2017
-95.97%
IPO
-96.62%
Name

22nd Century Group Inc

Chart & Performance

D1W1MN
P/E
—
P/S
0.42
EPS
—
Div Yield, %
—
Shrs. gr., 5y
92.60%
Rev. gr., 5y
-14.39%
Revenues
12m
-63.12%
000001,012,14118,7757,278,383528,9918,521,99812,279,97916,600,24426,426,34725,832,53028,111,00030,948,00062,111,00032,204,00011,878,000
Net income
-15m
L-89.23%
-59,786-29,672-82,146-55,469-89,933-1,353,903-6,735,281-26,153,158-15,595,358-11,031,931-11,581,430-13,029,117-7,966,911-24,195,578-19,711,000-32,609,000-59,801,000-140,775,000-15,164,000
CFO
-14m
L-73.91%
-43,186-33,547-42,451-87,591-32,004-3,449,430-1,764,4453,855,834-6,582,730-7,321,811-9,887,580-12,068,383-17,844,266-14,587,364-15,621,000-22,839,000-51,714,000-54,987,000-14,345,000
Earnings
Aug 11, 2025

Profile

22nd Century Group, Inc., an agricultural biotechnology company, focuses on tobacco harm reduction, reduced nicotine tobacco, and enhancing health and wellness through plant science for the life science and consumer products industries. It develops very low nicotine content tobacco and cigarette products under the VLN King and VLN Menthol King names; and SPECTRUM research cigarettes for use in independent clinical studies. The company has collaboration with Keygene N.V. to develop hemp/cannabis plants for exceptional cannabinoid profiles and other superior agronomic traits for medical, therapeutic, and agricultural uses, as well as other applications. 22nd Century Group, Inc. was founded in 1998 and is headquartered in Buffalo, New York.
URL
https://www.xxiicentury.com/
IPO date
Oct 17, 2006
Employees
198
Domiciled in
US
Incorporated in
US

Valuation

Title
USD in thousands, except ratios and share amounts
FYFYFYFYFYFYFYFYFYFY
2024‑122023‑122022‑122021‑122020‑122019‑122018‑122017‑122016‑122015‑12
Income
Revenues
11,878
-63.12%
32,204
-48.15%
62,111
100.69%
Cost of revenue
25,698
75,371
112,015
Unusual Expense (Income)
NOPBT
(13,820)
(43,167)
(49,904)
NOPBT Margin
Operating Taxes
30
47
(434)
Tax Rate
NOPAT
(13,850)
(43,214)
(49,470)
Net income
(15,164)
-89.23%
(140,775)
135.41%
(59,801)
83.39%
Dividends
(10,303)
Dividend yield
13.96%
Proceeds from repurchase of equity
16,132
27,899
34,851
BB yield
-21.86%
-11,575.19%
-314.13%
Debt
Debt current
2,015
6,853
1,589
Long-term debt
8,300
11,685
7,964
Deferred revenue
Other long-term liabilities
1,097
1,123
516
Net debt
5,893
16,480
(12,342)
Cash flow
Cash from operating activities
(14,345)
(54,987)
(51,714)
CAPEX
(5,617)
(4,429)
Cash from investing activities
(139)
16,816
22,578
Cash from financing activities
16,848
37,209
30,820
FCF
(14,166)
(20,770)
(69,637)
Balance
Cash
4,422
2,058
21,213
Long term investments
682
Excess cash
3,828
448
18,789
Stockholders' equity
(393,871)
(378,707)
(237,923)
Invested Capital
407,597
388,029
339,722
ROIC
ROCE
EV
Common stock shares outstanding
13,900
1,294
804
Price
5.31
2,751.77%
0.19
-98.65%
13.81
-70.21%
Market cap
73,808
30,522.70%
241
-97.83%
11,094
-63.22%
EV
79,701
16,721
(1,248)
EBITDA
(12,562)
(38,308)
(46,313)
EV/EBITDA
0.03
Interest
2,094
9,366
353
Interest/NOPBT